ICON Public Limited Company Retained Earnings 2011-2026 | ICLR

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.72 B	2.43 B	1.82 B	1.42 B	1.26 B	1.11 B	888 M	744 M	589 M	437 M	655 M	624 M	521 M	481 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.72 B	437 M	1.12 B

Quarterly Retained Earnings ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	1.43 B	1.42 B	1.34 B	1.43 B	1.36 B	1.26 B	1.16 B	1.07 B	1.02 B	1.11 B	1.02 B	1 B	952 M	888 M	872 M	790 M	735 M	743 M	697 M	623 M	569 M	588 M	624 M	560 M	499 M	436 M	543 M	711 M	711 M	655 M	707 M	689 M	660 M	624 M	590 M	562 M	540 M	521 M	500 M	482 M	489 M	481 M	486 M	489 M	476 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.43 B	436 M	780 M

Retained Earnings of other stocks in the Diagnostics research industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Akumin AKU	-280 M	-	-17.87 %	$ 25.9 M	Canada
Anixa Biosciences ANIX	-252 M	$ 3.11	-2.51 %	$ 101 K	USA
Centogene N.V. CNTG	-62.9 M	-	-6.23 %	$ 30.6 M	Germany
Accelerate Diagnostics AXDX	-607 M	-	-61.36 %	$ 2.46 M	USA
Brainsway Ltd. BWAY	-77.3 M	$ 22.32	-3.71 %	$ 99.4 M	Israel
BioNano Genomics BNGO	-693 M	$ 1.45	-3.67 %	$ 1.84 M	USA
Aspira Women's Health AWH	-499 M	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	-2.23 B	$ 30.5	-4.72 %	$ 328 M	China
Biocept BIOC	-298 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-170 M	-	-	$ 9.42 M	Israel
Castle Biosciences CSTL	-200 M	$ 40.78	1.92 %	$ 1.13 B	USA
Co-Diagnostics CODX	4.6 M	-	-	$ 79.8 M	USA
DexCom DXCM	1.02 B	$ 70.44	1.29 %	$ 27.2 B	USA
Oxford Immunotec Global PLC OXFD	-84 M	-	-	$ 562 M	Britain
Chembio Diagnostics CEMI	-154 M	-	0.22 %	$ 16.8 M	USA
Guardant Health GH	-2.58 B	$ 113.62	1.32 %	$ 13.9 B	USA
Global Cord Blood Corporation CO	2.89 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-624 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-150 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-4.94 B	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-424 M	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	440 M	-	-	$ 10.7 B	USA
Illumina ILMN	-1.24 B	$ 147.36	4.03 %	$ 23.4 B	USA
CareDx, Inc CDNA	-678 M	$ 20.08	0.35 %	$ 1.08 B	USA
Danaher Corporation DHR	44.2 B	$ 234.95	-0.44 %	$ 172 B	USA
Celcuity CELC	-272 M	$ 105.63	-1.25 %	$ 4.17 B	USA
DarioHealth Corp. DRIO	-349 M	$ 12.48	0.28 %	$ 354 M	Israel
Enzo Biochem ENZ	-294 M	-	-8.98 %	$ 14.8 K	USA
Fulgent Genetics FLGT	590 M	$ 27.65	-1.53 %	$ 836 M	USA
HTG Molecular Diagnostics HTGM	-230 M	-	-20.0 %	$ 1.06 M	USA
Exact Sciences Corporation EXAS	-4.5 B	$ 102.21	-0.22 %	$ 18.9 B	USA
Lantheus Holdings LNTH	446 M	$ 66.02	2.75 %	$ 4.57 B	USA
Medpace Holdings MEDP	8.17 M	$ 602.32	-1.41 %	$ 18.6 B	USA
IQVIA Holdings IQV	6.06 B	$ 234.18	-1.47 %	$ 42.5 B	USA
QIAGEN N.V. QGEN	2.45 B	-	-	$ 10.6 B	Niderland
Heska Corporation HSKA	-169 M	-	-	$ 1.31 B	USA
Neogen Corporation NEOG	-536 M	$ 9.28	0.27 %	$ 2.01 B	USA
National Research Corporation NRC	-30.5 M	$ 22.06	-0.72 %	$ 541 M	USA
Charles River Laboratories International CRL	1.81 B	$ 219.04	-0.3 %	$ 11.3 B	USA
OPKO Health OPK	-2.07 B	$ 1.3	1.56 %	$ 902 M	USA
Pacific Biosciences of California PACB	-1.84 B	$ 2.36	6.79 %	$ 599 M	USA
Quest Diagnostics Incorporated DGX	9.36 B	$ 188.87	-0.33 %	$ 21 B	USA
Biodesix BDSX	-462 M	$ 8.85	12.25 %	$ 1.15 B	USA
Mettler-Toledo International MTD	8.37 B	$ 1 409.56	-3.5 %	$ 29.9 B	Schweiz
Laboratory Corporation of America Holdings LH	8.3 B	$ 272.02	0.42 %	$ 22.8 B	USA
IDEXX Laboratories IDXX	5.33 B	$ 688.67	-3.73 %	$ 56.8 B	USA
Myriad Genetics MYGN	-757 M	$ 5.65	-4.56 %	$ 512 M	USA
ENDRA Life Sciences NDRA	-103 M	$ 4.67	-2.3 %	$ 2.51 M	USA
Agilent Technologies A	348 M	$ 135.52	-2.95 %	$ 41.2 B	USA